pharma · Ovarian Neoplasms · Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
TESARO Bio Netherlands
TESARO Bio Netherlands B.V.
TESARO Bio Netherlands events on NovaPharmaNews — congress presentations and investor conference coverage.
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 6
- Drugs
- 23
- Patents
- 0
Events
TESARO Bio Netherlands events on NovaPharmaNews — congress presentations and investor conference coverage.
TESARO Bio Netherlands events on NovaPharmaNews — congress presentations and investor conference coverage.